Gene Polymorphism-related Individual and Interracial Differences in the Outcomes of Androgen Deprivation Therapy for Prostate Cancer

Naohiro Fujimoto, masaki shiota, Ikko Tomisaki, Akinori Minato

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Among patients with prostate cancer, the prognosis after androgen deprivation therapy differs significantly among individuals and among races; however, the reasons underlying these differences are poorly understood. Several single nucleotide polymorphisms in genes associated with prostate cancer progression or castration resistance might serve as the host factor that influences prognosis and, thus, accounts for these individual and racial gaps in treatment outcomes. Accordingly, single nucleotide polymorphisms associated with treatment outcomes could be used as predictive and/or prognostic biomarkers for patient stratification and to identify personalized treatment and follow-up protocols. The present review has summarized the genetic polymorphisms that have been reported to associate with androgen deprivation therapy outcomes among patients with prostate cancer and compared the allele frequencies among different ethnic groups.

Original languageEnglish
Pages (from-to)337-342
Number of pages6
JournalClinical Genitourinary Cancer
Volume15
Issue number3
DOIs
Publication statusPublished - Jun 1 2017

Fingerprint

Individuality
Androgens
Prostatic Neoplasms
Single Nucleotide Polymorphism
Genes
Castration
Genetic Polymorphisms
Ethnic Groups
Gene Frequency
Therapeutics
Biomarkers

All Science Journal Classification (ASJC) codes

  • Oncology
  • Urology

Cite this

Gene Polymorphism-related Individual and Interracial Differences in the Outcomes of Androgen Deprivation Therapy for Prostate Cancer. / Fujimoto, Naohiro; shiota, masaki; Tomisaki, Ikko; Minato, Akinori.

In: Clinical Genitourinary Cancer, Vol. 15, No. 3, 01.06.2017, p. 337-342.

Research output: Contribution to journalReview article

@article{93c4bd8b946a4a3d989341d3fed3f83f,
title = "Gene Polymorphism-related Individual and Interracial Differences in the Outcomes of Androgen Deprivation Therapy for Prostate Cancer",
abstract = "Among patients with prostate cancer, the prognosis after androgen deprivation therapy differs significantly among individuals and among races; however, the reasons underlying these differences are poorly understood. Several single nucleotide polymorphisms in genes associated with prostate cancer progression or castration resistance might serve as the host factor that influences prognosis and, thus, accounts for these individual and racial gaps in treatment outcomes. Accordingly, single nucleotide polymorphisms associated with treatment outcomes could be used as predictive and/or prognostic biomarkers for patient stratification and to identify personalized treatment and follow-up protocols. The present review has summarized the genetic polymorphisms that have been reported to associate with androgen deprivation therapy outcomes among patients with prostate cancer and compared the allele frequencies among different ethnic groups.",
author = "Naohiro Fujimoto and masaki shiota and Ikko Tomisaki and Akinori Minato",
year = "2017",
month = "6",
day = "1",
doi = "10.1016/j.clgc.2017.01.006",
language = "English",
volume = "15",
pages = "337--342",
journal = "Clinical Genitourinary Cancer",
issn = "1558-7673",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Gene Polymorphism-related Individual and Interracial Differences in the Outcomes of Androgen Deprivation Therapy for Prostate Cancer

AU - Fujimoto, Naohiro

AU - shiota, masaki

AU - Tomisaki, Ikko

AU - Minato, Akinori

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Among patients with prostate cancer, the prognosis after androgen deprivation therapy differs significantly among individuals and among races; however, the reasons underlying these differences are poorly understood. Several single nucleotide polymorphisms in genes associated with prostate cancer progression or castration resistance might serve as the host factor that influences prognosis and, thus, accounts for these individual and racial gaps in treatment outcomes. Accordingly, single nucleotide polymorphisms associated with treatment outcomes could be used as predictive and/or prognostic biomarkers for patient stratification and to identify personalized treatment and follow-up protocols. The present review has summarized the genetic polymorphisms that have been reported to associate with androgen deprivation therapy outcomes among patients with prostate cancer and compared the allele frequencies among different ethnic groups.

AB - Among patients with prostate cancer, the prognosis after androgen deprivation therapy differs significantly among individuals and among races; however, the reasons underlying these differences are poorly understood. Several single nucleotide polymorphisms in genes associated with prostate cancer progression or castration resistance might serve as the host factor that influences prognosis and, thus, accounts for these individual and racial gaps in treatment outcomes. Accordingly, single nucleotide polymorphisms associated with treatment outcomes could be used as predictive and/or prognostic biomarkers for patient stratification and to identify personalized treatment and follow-up protocols. The present review has summarized the genetic polymorphisms that have been reported to associate with androgen deprivation therapy outcomes among patients with prostate cancer and compared the allele frequencies among different ethnic groups.

UR - http://www.scopus.com/inward/record.url?scp=85011589625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011589625&partnerID=8YFLogxK

U2 - 10.1016/j.clgc.2017.01.006

DO - 10.1016/j.clgc.2017.01.006

M3 - Review article

C2 - 28188049

AN - SCOPUS:85011589625

VL - 15

SP - 337

EP - 342

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

SN - 1558-7673

IS - 3

ER -